|
|
|
|
| LEADER |
01888nam a22003495i 4500 |
| 001 |
978-3-319-52175-6 |
| 005 |
20191024011149.0 |
| 007 |
cr nn 008mamaa |
| 008 |
170206s2017 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319521756
|
| 024 |
7 |
|
|a 10.1007/978-3-319-52175-6
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Pharmacology and Therapeutics of Asthma and COPD
|c edited by Clive P. Page, Peter J. Barnes.
|
| 250 |
|
|
|a 1st ed. 2017.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2017.
|
| 300 |
|
|
|a X, 285 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Handbook of Experimental Pharmacology,
|v 237
|
| 505 |
0 |
|
|a Pathogenesis of bronchial asthma and chronic obstructive pulmonary disease - common diseases with unmet needs -- Beta 2 agonists -- Muscarinic receptor antagonists -- Xanthines and Phosphodiesterase inhibitors -- Glucocorticosteroids -- Fixed dose combination inhalers -- Anti-IgE and biologic approaches for the treatment of asthma -- Leukotriene receptor antagonists and anti-allergy drugs -- Novel anti-inflammatory drugs -- Bifunctional drugs for the treatment of respiratory diseases -- Drugs affecting TRP channels -- Evaluation of new drugs for asthma and COPD: endpoints, biomarkers and clinical trial design -- Drug delivery devices for inhaled medicines. .
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Respiratory organs-Diseases.
|
| 650 |
|
0 |
|a Dermatology.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Pneumology/Respiratory System.
|
| 650 |
2 |
4 |
|a Dermatology.
|
| 700 |
1 |
|
|a Page, Clive P.
|e editor.
|
| 700 |
1 |
|
|a Barnes, Peter J.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-52175-6
|